Shawn R Lockhart
Shawn R Lockhart
Verified email at cdc.gov
Title
Cited by
Cited by
Year
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
SR Lockhart, KA Etienne, S Vallabhaneni, J Farooqi, A Chowdhary, ...
Clinical Infectious Diseases 64 (2), 134-140, 2017
6572017
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004
SR Lockhart, MA Abramson, SE Beekmann, G Gallagher, S Riedel, ...
Journal of clinical microbiology 45 (10), 3352-3359, 2007
5252007
Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata
MA Pfaller, M Castanheira, SR Lockhart, AM Ahlquist, SA Messer, ...
Journal of clinical microbiology 50 (4), 1199-1203, 2012
3712012
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011
AA Cleveland, MM Farley, LH Harrison, B Stein, R Hollick, SR Lockhart, ...
Clinical infectious diseases 55 (10), 1352-1361, 2012
3312012
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
MA Pfaller, DJ Diekema, D Andes, MC Arendrup, SD Brown, SR Lockhart, ...
Drug Resistance Updates 14 (3), 164-176, 2011
3242011
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus — United States, May 2013–Augustá…
S Vallabhaneni, A Kallen, S Tsay, N Chow, R Welsh, J Kerins, SK Kemble, ...
Morbidity and Mortality Weekly Report 65 (44), 1234-1237, 2016
2852016
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two US cities from 2008 to 2011
SR Lockhart, N Iqbal, AA Cleveland, MM Farley, LH Harrison, CB Bolden, ...
Journal of clinical microbiology 50 (11), 3435-3442, 2012
2632012
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Groupá…
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
2502020
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011
R Neblett Fanfair, K Benedict, J Bos, SD Bennett, YC Lo, T Adebanjo, ...
New England journal of medicine 367 (23), 2214-2225, 2012
2322012
Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene
SR Lockhart, JP Frade, KA Etienne, MA Pfaller, DJ Diekema, SA Balajee
Antimicrobial agents and chemotherapy 55 (9), 4465-4468, 2011
2302011
In Candida albicans, White-Opaque Switchers Are Homozygous for Mating Type
SR Lockhart, C Pujol, KJ Daniels, MG Miller, AD Johnson, MA Pfaller, ...
Genetics 162 (2), 737-745, 2002
2302002
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related speciesá…
SR Lockhart, SA Messer, MA Pfaller, DJ Diekema
Journal of clinical microbiology 46 (8), 2659-2664, 2008
2252008
Frequency, intensity, species, and strains of oral Candida vary as a function of host age.
CL Kleinegger, SR Lockhart, K Vargas, DR Soll
Journal of clinical microbiology 34 (9), 2246-2254, 1996
2251996
Natural defenses against Candida colonization breakdown in the oral cavities of the elderly
SR Lockhart, S Joly, K Vargas, J Swails-Wenger, L Enger, DR Soll
Journal of dental research 78 (4), 857-868, 1999
2241999
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values forá…
A Espinel-Ingroff, AI Aller, E Canton, LR Casta˝ˇn-Olivares, A Chowdhary, ...
Antimicrobial agents and chemotherapy 56 (11), 5898-5906, 2012
2202012
Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008–2013: results from population-based surveillance
AA Cleveland, LH Harrison, MM Farley, R Hollick, B Stein, TM Chiller, ...
PloS one 10 (3), e0120452, 2015
2162015
Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 forá…
C Pujol, S Joly, SR Lockhart, S Noel, M Tibayrenc, DR Soll
Journal of Clinical Microbiology 35 (9), 2348-2358, 1997
2161997
Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, MC Arendrup, MA Pfaller, LX Bonfietti, B Bustamante, ...
Antimicrobial agents and chemotherapy 57 (12), 5836-5842, 2013
1882013
Most frequent scenario for recurrent Candida vaginitis is strain maintenance with" substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, andá…
SR Lockhart, BD Reed, CL Pierson, DR Soll
Journal of Clinical Microbiology 34 (4), 767-777, 1996
1801996
Opaque cells signal white cells to form biofilms in Candida albicans
KJ Daniels, T Srikantha, SR Lockhart, C Pujol, DR Soll
The EMBO journal 25 (10), 2240-2252, 2006
1772006
The system can't perform the operation now. Try again later.
Articles 1–20